Stocks
Repare Therapeutics IncRPTX
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing precision oncology therapies, with a focus on small molecule drugs targeting DNA repair pathways. Its lead programs are in early clinical trials, and investors track it for its potential in treating genetically defined cancers.
Congressional Interest in Repare Therapeutics Inc (RPTX)
2 members of Congress have disclosed 2 trades in Repare Therapeutics Inc (RPTX), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading RPTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-08-02 | Rohit Khanna | sell | $1K-$15K |
| 2021-02-15 | Kurt Schrader | buy | $1K-$15K |